News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3124last 7d
510● bullish (7d)
313● bearish (7d)
227publishers
Insider Monkey139d agoneutral
Could This FDA Milestone Unlock Gilead’s (GILD) Next Big Growth Driver?Simply Wall St.139d agobullish
Merck (MRK) Wins FDA Expansions, Posts HIV Data, And Ends Lung Cancer TrialExec Edge143d agoneutral
VERAXA Unveils Cancer Therapy Platform, Sparks Partnering Talks at BIO 2026Insider Monkey146d agoneutral
Regulatory Milestone Boosts Gilead’s Presence in Liver Disease CareInsider Monkey148d agoneutral
Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBCInsider Monkey150d agobullish
Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now?Insider Monkey151d agoneutral
Gilead Sciences, Inc. (GILD): a Top Deep Value Stock Making Progress on Pipeline DevelopmentSimply Wall St.151d agoneutral
Cencora Kite Deal Highlights CAR T Growth And Undervalued Share Price PotentialSimply Wall St.152d agoneutral
Gilead’s Mixed Trial News Puts HIV Progress And Oncology Risks In FocusBioPharma Dive152d agoneutral
Merck, Gilead report mixed outcomes in key lung cancer, HIV studiesSimply Wall St.152d agoneutral
Will HIV Win and Lung Cancer Loss in Trials Recast Merck’s (MRK) Risk Reward Narrative?MarketBeat153d agoneutral
Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data AheadInsider Monkey155d agoneutral
Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline